Clover Biopharmaceuticals, Ltd. (HKG:2197)
2.140
+0.240 (12.63%)
At close: Mar 10, 2026
548.48% (1Y)
| Market Cap | 2.47B |
| Revenue (ttm) | 56.73M |
| Net Income (ttm) | -996.69M |
| Shares Out | 1.30B |
| EPS (ttm) | -0.79 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,839,500 |
| Average Volume | 3,431,079 |
| Open | 1.890 |
| Previous Close | 1.900 |
| Day's Range | 1.890 - 2.210 |
| 52-Week Range | 0.185 - 3.180 |
| Beta | 3.42 |
| RSI | 51.77 |
| Earnings Date | Mar 27, 2026 |